10-Q 1 d561463d10q.htm FORM 10-Q Form 10-Q
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: June 30, 2013

or

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission file number 333-135172

 

 

CRC HEALTH CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   73-1650429

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

20400 Stevens Creek Boulevard,

Suite 600, Cupertino, California

  95014
(Address of principal executive offices)   (Zip code)

(877) 272-8668

(Registrant’s telephone number, including area code)

 

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer   ¨    Accelerated filer   ¨
Non-accelerated filer   x    Smaller reporting company   ¨

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

The total number of shares of the registrant’s common stock, par value of $0.001 per share, outstanding as of August 14, 2013 was 1,000.

 

 

 


Table of Contents

CRC HEALTH CORPORATION

INDEX

 

             Page No.  
Part I.   Financial Information   
  Item 1.   Financial Statements (Unaudited)   
   

Condensed Consolidated Balance Sheets as of June 30, 2013 and December 31, 2012

     2   
   

Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2013 and 2012

     3   
   

Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and six months ended June 30, 2013 and 2012

     4   
   

Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2013 and 2012

     5   
    Notes to Condensed Consolidated Financial Statements      6   
  Item 2.  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

     26   
  Item 3.   Quantitative and Qualitative Disclosure About Market Risk      32   
  Item 4.   Controls and Procedures      32   
Part II.   Other Information   
  Item 1.   Legal Proceedings      33   
  Item 1A.   Risk Factors      34   
  Item 6.   Exhibits      34   
Signature      35   
Exhibit Index      36   


Table of Contents

Forward-Looking Statements

This Quarterly Report on Form 10-Q, including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 2 of Part I of this Quarterly Report, includes or may include “forward-looking statements.” All statements included herein, other than statements of historical fact, may constitute forward-looking statements. In some cases you can identify forward-looking statements by terminology such as “may,” “should” or “could.” Generally, the words “anticipates,” “believes,” “expects,” “intends,” “estimates,” “projects,” “plans” and similar expressions identify forward-looking statements. Although CRC Health Corporation (“CRC”) believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct. Important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, among others, the following factors: our substantial indebtedness; unfavorable economic conditions that have and could continue to negatively impact our revenues; changes in reimbursement rates for services provided; the failure to comply with extensive laws and governmental regulations given the highly regulated industry in which we operate and the ever changing nature of these laws and regulations; the significant economic contribution that certain regions and programs have to our operating results; claims and legal actions by patients, students, employees and others; failure to cultivate new, or maintain existing relationships with patient referral sources; competition; shortage in qualified healthcare workers; our employees election of union representation; difficult, costly or unsuccessful integrations of acquisitions; accidents or other incidents at our programs; defaults by borrowers in our loan program; limited history of profitability; potential conflicts with our financial sponsors; natural disasters; adverse media; deficiencies in our internal controls; regulatory risks and other risks that are described herein, including but not limited to the items discussed in “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012 filed on April 1, 2013, and that are otherwise described from time to time in CRC’s Securities and Exchange Commission filings after this Quarterly Report. CRC assumes no obligation and does not intend to update these forward-looking statements.

All references in this report to the “Company,” “we,” “our,” and “us” mean, unless the context indicates otherwise, CRC Health Corporation and its subsidiaries on a consolidated basis.

 

1


Table of Contents

CRC HEALTH CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

JUNE 30, 2013 AND DECEMBER 31, 2012

(In thousands, except share amounts)

 

     June 30,
2013
    December 31,
2012
 

Assets

    

Current assets:

    

Cash and cash equivalents

   $ 11,040      $ 19,058   

Restricted cash

     280        364   

Accounts receivable, net

     39,331        36,737   

Prepaid expenses

     7,430        4,781   

Other current assets

     2,598        2,591   

Income taxes receivable

     3,094        1,109   

Deferred income taxes

     6,352        6,352   

Current assets of discontinued operations

     3,135        2,759   
  

 

 

   

 

 

 

Total current assets

     73,260        73,751   

Property and equipment, net

     131,406        130,381   

Goodwill

     519,093        518,953   

Other intangible assets, net

     281,079        294,085   

Other assets, net

     18,305        20,396   
  

 

 

   

 

 

 

Total assets

   $ 1,023,143      $ 1,037,566   
  

 

 

   

 

 

 

Liabilities and stockholders’ equity

    

Current liabilities:

    

Accounts payable

   $ 7,507      $ 6,801   

Accrued payroll and related expenses

     19,292        18,333   

Accrued interest

     9,334        9,412   

Accrued expenses

     12,575        8,721   

Current portion of long-term debt

     —          4,840   

Deferred revenue

     14,169        9,494   

Other current liabilities

     1,303        1,592   

Current liabilities of discontinued operations

     2,287        2,372   
  

 

 

   

 

 

 

Total current liabilities

     66,467        61,565   

Long-term debt

     567,174        584,535   

Other long-term liabilities

     8,642        8,740   

Long-term liabilities of discontinued operations

     5,838        6,275   

Deferred income taxes

     107,310        107,289   
  

 

 

   

 

 

 

Total liabilities

     755,431        768,404   
  

 

 

   

 

 

 

Commitments and contingencies

    

Stockholders’ equity

    

Common stock, $0.001 par value - 1,000 shares authorized, issued and outstanding

     —          —     

Additional paid-in capital

     465,665        464,932   

Accumulated deficit

     (197,913     (195,699

Accumulated other comprehensive loss

     (40     (71
  

 

 

   

 

 

 

Total equity

     267,712        269,162   
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 1,023,143      $ 1,037,566   
  

 

 

   

 

 

 

See notes to condensed consolidated financial statements.

 

2


Table of Contents

CRC HEALTH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2013 AND 2012

(In thousands)

 

     Three Months Ended June 30,     Six Months Ended June 30,  
     2013     2012     2013     2012  

Net client service revenues

   $ 118,575      $ 114,977      $ 229,159      $ 223,199   

Operating expenses:

        

Salaries and benefits

     56,849        54,585        112,817        109,173   

Facilities and other operating costs

     37,384        33,252        70,972        65,470   

Provision for doubtful accounts

     1,851        1,465        4,026        3,808   

Depreciation and amortization

     5,332        5,027        10,187        9,921   

Asset impairments

     10,859        —          10,859        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     112,275        94,329        208,861        188,372   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     6,300        20,648        20,298        34,827   

Interest expense

     (12,163     (12,552     (23,642     (24,338

Other income

     241        251        503        494   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

     (5,622     8,347        (2,841     10,983   

Income tax expense (benefit)

     (2,295     3,500        (1,112     4,684   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations, net of tax

     (3,327     4,847        (1,729     6,299   

Loss from discontinued operations, net of tax

     (274     (453     (485     (1,246
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ (3,601   $ 4,394      $ (2,214   $ 5,053   
  

 

 

   

 

 

   

 

 

   

 

 

 

See notes to condensed consolidated financial statements.

 

3


Table of Contents

CRC HEALTH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2013 AND 2012

(In thousands)

 

     Three Months Ended June 30,      Six Months Ended June 30,  
     2013     2012      2013     2012  

Net income (loss)

   $ (3,601   $ 4,394       $ (2,214   $ 5,053   

Other comprehensive income:

         

Net change in unrealized loss on cash flow hedges (net of tax of $5 and $21 for the three and six months ended June 30, 2013, respectively)

     7        —           31        —     
  

 

 

   

 

 

    

 

 

   

 

 

 

Total comprehensive income (loss)

   $ (3,594   $ 4,394       $ (2,183   $ 5,053   
  

 

 

   

 

 

    

 

 

   

 

 

 

See notes to condensed consolidated financial statements.

 

4


Table of Contents

CRC HEALTH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

FOR THE SIX MONTHS ENDED JUNE 30, 2013 AND 2012

 

     Six Months Ended June 30,  
     2013     2012  

Cash flows from operating activities:

    

Net income (loss)

   $ (2,214   $ 5,053   

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation and amortization

     10,187        10,008   

Amortization of debt discount and capitalized financing costs

     2,122        3,014   

Asset impairments

     10,859        —     

Loss on disposal of property and equipment

     190        418   

Provision for doubtful accounts

     4,008        3,954   

Stock-based compensation

     1,332        1,016   

Deferred income taxes

     21        (804

Changes in assets and liabilities:

    

Restricted cash

     84        (226

Accounts receivable

     (6,599     (1,878

Prepaid expenses

     (2,642     1,118   

Income taxes receivable and payable

     (2,372     2,705   

Other current assets

     (7     (170

Accounts payable

     841        (300

Accrued liabilities

     4,924        2,873   

Other current liabilities

     4,342        6,345   

Other long-term assets

     821        (853

Other long-term liabilities

     (529     315   
  

 

 

   

 

 

 

Net cash provided by operating activities

     25,368        32,588   
  

 

 

   

 

 

 

Cash flows from investing activities:

    

Additions of property and equipment

     (9,432     (7,341

Proceeds from sale of property and equipment

     36        —     

Acquisition of business, net of cash acquired

     (140     —     

Other investing activities

     —          (29
  

 

 

   

 

 

 

Net cash used in investing activities

     (9,536     (7,370
  

 

 

   

 

 

 

Cash flows from financing activities:

    

Borrowings of long-term debt

     —          84,096   

Repayment of long-term debt

     (5,019     (88,099

Borrowings on revolving line of credit

     —          18,000   

Repayments on revolving line of credit

     (17,995     (13,505

Capital distributed to Parent

     (599     (9,524

Capitalized financing costs

     (217     (2,772

Other financing activities

     (20     —     
  

 

 

   

 

 

 

Net cash used in financing activities

     (23,850     (11,804
  

 

 

   

 

 

 

Net increase (decrease) in cash and cash equivalents

     (8,018     13,414   

Cash and cash equivalents — beginning of period

     19,058        10,183   
  

 

 

   

 

 

 

Cash and cash equivalents — end of period

   $ 11,040      $ 23,597   
  

 

 

   

 

 

 

See notes to condensed consolidated financial statements.

 

5


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

June 30, 2013

NOTE 1. OVERVIEW AND BASIS OF PRESENTATION

Overview

CRC Health Corporation (“the Company”) is a wholly owned subsidiary of CRC Health Group, Inc., referred to as “the Group” or “the Parent.” The Company is headquartered in Cupertino, California, and through its wholly owned subsidiaries provides treatment services related to substance abuse, troubled youth and other addiction diseases and behavioral disorders.

Basis of Presentation

The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X, without audit. Accordingly, they do not include all of the information required by accounting principles generally accepted in the United States of America for annual financial statements. The unaudited condensed consolidated balance sheet as of December 31, 2012 has been derived from our audited financial statements.

In the opinion of management, these unaudited condensed consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, necessary to present fairly the financial position of the Company, its results of operations, and its cash flows. These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012.

Principles of Consolidation — The Company’s condensed consolidated financial statements include the accounts of CRC Health Corporation and its consolidated subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates — Preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Company’s condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.

Reclassifications: Discontinued Operations — The condensed consolidated statements of operations have been reclassified for all periods presented to reflect the presentation of closed or sold facilities as discontinued operations (see Note 8). Unless noted otherwise, discussions in the notes to the condensed consolidated financial statements pertain to continuing operations.

Corrections to Condensed Consolidated Balance Sheet as of December 31, 2012

Subsequent to the issuance of the Company’s 2012 consolidated financial statements, management determined that certain impairments of intangible assets (both those subject to amortization and those not subject to amortization) recorded primarily in discontinued operations in the periods from 2008 through December 31, 2012 were incorrectly computed and recorded due to errors in the allocation of such amounts to specific facilities and other mathematical mistakes. The actual aggregate intangible asset impairment recognized through December 31, 2012 exceeded the intangible asset impairment that should have been recognized by $1.2 million. As a result, certain amounts presented in the Company’s condensed consolidated balance sheet as of December 31, 2012 have been restated from the amounts previously reported to correct such errors as shown in the table below. We believe these corrections are not material to our previously issued consolidated financial statements.

Condensed Consolidated Balance Sheet as of December 31, 2012 (in thousands):

 

     As Previously
Reported
    Corrections      As Restated  

Current assets of discontinued operations

   $ 2,623      $ 136       $ 2,759   

Total current assets

     73,615        136         73,751   

Other intangible assets, net

     292,846        1,239         294,085   

Total assets

     1,036,191        1,375         1,037,566   

Accumulated deficit

     (197,074     1,375         (195,699

Total equity

     267,787        1,375         269,162   

Total liabilities and stockholders’ equity

     1,036,191        1,375         1,037,566   

 

6


Table of Contents

Corrections to Condensed Consolidated Statements of Operations, Comprehensive Income and Cash Flows for the periods ended June 30, 2012 —

The Company has restated the condensed consolidated statements of operations and comprehensive income for the three and six months ended June 30, 2012 and the condensed consolidated statement of cash flows for the six months ended June 30, 2012 to correct intangible asset amortization related to the intangible asset impairments discussed above; and to correct other immaterial out of period adjustments that were previously identified, recorded and disclosed in Note 1 of the financial statements included in the Company’s 2012 Annual Report on Form 10-K and the June 30, 2012 Form 10-Q, so such adjustments are recorded in the proper period. We believe these corrections are not material to our previously issued annual or interim consolidated financial statements.

The effects of the correction of the intangible asset amortization error and the out of period adjustments are as follows:

 

   

Additional aggregate intangible asset amortization of $0.1 million and $0.2 million in the three and six months ended June 30, 2012, respectively, has been recorded;

 

   

Management fees reimbursable to the Company’s principal shareholder of $0.7 million that were previously expensed in “supplies, facilities and other operating costs” in the quarter ended June 30, 2012 have been correctly recorded in 2011;

 

   

Leasehold improvements aggregating $0.4 million previously expensed in “supplies, facilities and other operating costs” in the quarter ended June 30, 2012 have been correctly recorded in the years 2009 through 2011;

 

   

Adjustments to decrease “supplies, facilities, and other operating costs” by $0.9 million and to increase “net loss attributable to noncontrolling interest” that were previously recorded in the quarter ended June 30, 2012 have been correctly recorded in 2011;

 

   

Depreciation related to leasehold improvements costs aggregating $0.6 million previously expensed in “supplies, facilities and other operating costs” in the quarter ended December 31, 2012 have been correctly recorded in the years 2006 through 2012; and

 

   

Adjustments have been recorded to reflect the income tax effects related to the above corrections.

The following tables summarize the effects of the discontinued operations reclassifications and the corrections on the Company’s condensed consolidated statements of operations for three and six months ended June 30, 2012 (in thousands):

 

     For the Three Months Ended June 30, 2012  
     As
Previously
Reported
    Discontinued
Operations
Reclassifications
    Out of Period
Corrections
    Intangible  Assets
Amortization
Corrections
    As
Restated
 

Net client service revenues

   $ 115,567      $ (590   $ —        $ —        $ 114,977   

Operating expenses:

          

Salaries and benefits

     53,971        (320     934          54,585   

Facilities and other operating costs

     34,728        (361     (1,115       33,252   

Provision for doubtful accounts

     1,505        (40     —          —          1,465   

Depreciation and amortization

     4,974        (52     25        80        5,027   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     95,178        (773     (156     80        94,329   

Operating income

     20,389        183        156        (80     20,648   

Interest expense

     (12,553     1        —          —          (12,552

Other income

     251        —          —          —          251   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations before income taxes

     8,087        184        156        (80     8,347   

Income tax expense

     3,390        78        65        (33     3,500   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations, net of tax

     4,697        106        91        (47     4,847   

Loss from discontinued operations, net of tax

     (382     (106     35          (453
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

     4,315        —          126        (47     4,394   

Net loss attributable to noncontrolling interest

     (934     —          934        —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to CRC Health Corporation

   $ 3,381      $ —        $ 1,060      $ (47   $ 4,394   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

     For the Six Months Ended June 30, 2012  
     As
Previously
Reported
    Discontinued
Operations
Reclassifications
    Out of Period
Corrections
    Intangible  Assets
Amortization
Corrections
    As
Restated
 

Net client service revenues

   $ 224,471      $ (1,272   $ —        $ —        $ 223,199   

Operating expenses:

          

Salaries and benefits

     108,915        (676     934        —          109,173   

Facilities and other operating costs

     67,250        (706     (1,074     —          65,470   

Provision for doubtful accounts

     3,873        (65     —          —          3,808   

Depreciation and amortization

     9,798        (87     50        160        9,921   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     189,836        (1,534     (90     160        188,372   

Operating income

     34,635        262        90        (160     34,827   

Interest expense

     (24,340     2        —          —          (24,338

Other income

     494        —          —          —          494   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations before income taxes

     10,789        264        90        (160     10,983   

Income tax expense

     4,602        112        38        (68     4,684   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations, net of tax

     6,187        152        52        (92     6,299   

Loss from discontinued operations, net of tax

     (1,129     (152     35        —          (1,246
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

     5,058        —          87        (92     5,053   

Net loss attributable to noncontrolling interest

     (934     —          934       
—  
  
    —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to CRC Health Corporation

   $ 4,124      $ —        $ 1,021      $ (92   $ 5,053   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

The following tables summarize the effects of the corrections on the Company’s condensed consolidated statements of comprehensive income for the three and six months ended June 30, 2012 (in thousands):

 

     For the Three Months Ended June 30, 2012  
     As
Previously
Reported
    Out of Period
Corrections
     Intangible Assets
Amortization
Corrections
    As
Restated
 

Net income

   $ 4,315      $ 126       $ (47   $ 4,394   

Other comprehensive income:

     —          —           —          —     
  

 

 

   

 

 

    

 

 

   

 

 

 

Total comprehensive income

     4,315        126         (47     4,394   

Net loss attributable to noncontrolling interest

     (934     934         —       
  

 

 

   

 

 

    

 

 

   

 

 

 

Net income attributable to CRC Health Corporation

   $ 3,381      $ 1,060       $ (47   $ 4,394   
  

 

 

   

 

 

    

 

 

   

 

 

 
     For the Six Months Ended June 30, 2012  
     As
Previously
Reported
    Out of Period
Corrections
     Intangible Assets
Amortization
Corrections
    As
Restated
 

Net income

   $ 5,058      $ 87       $ (92   $ 5,053   

Other comprehensive income:

     —          —           —          —     
  

 

 

   

 

 

    

 

 

   

 

 

 

Total comprehensive income

     5,058        87         (92     5,053   

Net loss attributable to noncontrolling interest

     (934     934         —          —     
  

 

 

   

 

 

    

 

 

   

 

 

 

Net income attributable to CRC Health Corporation

   $ 4,124      $ 1,021       $ (92   $ 5,053   
  

 

 

   

 

 

    

 

 

   

 

 

 

The following tables summarize the effects of the corrections on the Company’s condensed consolidated statement of cash flows for six months ended June 30, 2012 (in thousands):

 

     For the Six Months Ended June 30, 2012  
     As
Previously
Reported
    Out of Period
Corrections
    Intangible Assets
Amortization
Corrections
    As
Restated
 

Cash flows from operating activities:

        

Net income

   $ 5,058      $ 87      $ (92   $ 5,053   

Adjustments to reconcile net income to net cash provided by operating activities:

        

Depreciation and amortization

     9,798        50        160        10,008   

Amortization of debt discount and capitalized financing costs

     3,014        —          —          3,014   

Loss on disposal of property and equipment

     843        (425     —          418   

Provision for doubtful accounts

     3,954        —          —          3,954   

Stock-based compensation

     1,016        —          —          1,016   

Deferred income taxes

     (797     61        (68     (804

Changes in assets and liabilities:

        

Restricted cash

     (226     —          —          (226

Accounts receivable

     (1,878     —          —          (1,878

Prepaid expenses

     1,118        —          —          1,118   

Income taxes receivable and payable

     2,705        —          —          2,705   

Other current assets

     (170     —          —          (170

Accounts payable

     (300     —          —          (300

Accrued liabilities

     2,646        227        —          2,873   

Other current liabilities

     6,345        —          —          6,345   

Other long-term assets

     (853     —          —          (853

Other long-term liabilities

     315        —          —          315   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by operating activities

   $ 32,588      $ —        $ —        $ 32,588   
  

 

 

   

 

 

   

 

 

   

 

 

 

NOTE 2. INCOME TAXES

The Company calculates its income tax expense for interim periods by applying the full year’s estimated effective tax rate in its financial statements for interim periods (in thousands, except percentages). The three and six months ended June 30, 2012 reflect the effects of the corrections in Note 1.

 

     Three Months Ended June 30,     Six Months Ended June 30,  
     2013     2012     2013     2012  

Income tax expense (benefit) from continuing operations

   $ (2,295   $ 3,500      $ (1,112   $ 4,684   

Effective tax rate

     40.8     41.9     39.1     42.6

The Company’s effective tax rate of 40.8% and 39.1% for the three and six months ended June 30, 2013, respectively, differed from the effective tax rate for the three and six months ended June 30, 2012 of 41.9% and 42.6%, respectively, primarily due to the decreases to state tax expense and interest expense related to uncertain tax positions.

The Company’s effective tax rate of 40.8% and 39.1% for the three and six months ended June 30, 2013, respectively, differed from the U.S. federal statutory income tax rate of 35.0%, due primarily to state tax expense.

NOTE 3. LONG-TERM DEBT

Long-term debt as of June 30, 2013 and December 31, 2012 consists of the following (in thousands):

Term Loans and Revolving Line of Credit

 

     June 30,
2013
     December 31,
2012
 

Term loans, net of discount of $2,250 in 2013 and $2,751 in 2012

   $ 381,555       $ 385,875   

Revolving line of credit

     9,005         27,000   

Senior subordinated notes, net of discount of $682 in 2013 and $814 in 2012

     176,614         176,482   

Other

     —           18   
  

 

 

    

 

 

 

Total debt

     567,174         589,375   

Less: current portion of long-term debt

     —           (4,840
  

 

 

    

 

 

 

Total long-term debt

   $ 567,174       $ 584,535   
  

 

 

    

 

 

 

Term Loans

On March 7, 2012, the aggregate principal amount of $80.9 million of Term Loans (the “Term Loans B-1”) was refinanced with cash proceeds (net of related fees and expenses) of an aggregate principal amount of $87.6 million of new Term Loans that mature on November 16, 2015 (the “Term Loans B-3”). New creditors and existing Term Loans B-1 creditors represented $67.0 million and $20.6 million of the Term Loans B-3 principal amount, respectively. Of the $20.6 million related to existing creditors, $6.1 million was contributed as additional Term Loan B-3 principal. As a part of the refinancing, the Company repaid $66.4 million of the aggregate principal Term Loans B-1. This repayment was recognized as an extinguishment of debt and $0.2 million of the remaining unamortized issuance costs related to Term Loans B-1 were charged to interest expense during the three months ended March 31, 2012. The Company recognized the refinancing of the remaining aggregate principal amount of $14.5 million with existing Term Loans B-1 creditors as a modification of debt. Refinancing costs of $0.5 million associated with the

 

7


Table of Contents

modified debt were charged to interest expense during the three months ended March 31, 2012. The remaining debt issuance costs of $2.2 million related to the refinancing were capitalized and are being amortized over the life of the Term Loans B-3 using the effective interest rate method. The Term Loans B-3 was issued with an original issue discount of 4.00% which is being amortized over the term of the Term Loans B-3 using the effective interest rate method.

As of June 30, 2013, $82.8 million, net of discount of $2.2 million, are outstanding on the Term Loans B-3. Interest on these Term Loans B-3 is payable quarterly at: (i) for LIBOR loans for any interest period, a rate per annum equal to the LIBOR rate as determined by the administrative agent (but not less than 1.50%), plus an applicable margin of 7.00%, subject to an increase to 8.00% during any period that the Company’s public corporate family rating from Moody’s is not at least B3 or the Company’s public corporate credit rating from Standard & Poor’s Ratings Services (“S&P”) is not at least B-, and (ii) for base rate loans, a rate per annum equal to the greater of (x) the prime rate of the administrative agent and (y) the federal funds rate plus one-half of 1.00% (but, in either case, not less than 2.50%), plus an applicable margin of 6.00%, subject to an increase to 7.00% during any period that the Company’s public corporate family rating from Moody’s is not at least B3 or the Company’s public corporate rating credit rating from S&P is not at least B-. As of June 30, 2013, the entire amount of the Term Loan B-3 consisted of LIBOR loans and the interest rate thereon was 8.5%.

The Term Loans B-3 are payable in quarterly principal installments of $0.1 million on December 31, 2014 and $0.7 million over the payment period between March 31, 2015 and September 30, 2015, with the remainder due on the maturity date of November 16, 2015.

Under the terms of this refinancing, the Company was required to pay and paid, a fee equal to 1.00% of the outstanding principal amount of such lender’s Term Loans B-3 as of March 31, 2013, which totaled $0.9 million. The Company is also required to pay (i) on March 31, 2014, a fee equal to 1.50% of the outstanding principal amount of such lender’s Term Loans B-3 as of such date and (ii) on the Maturity Date, a fee equal to 1.50% of the outstanding principal amount of such lender’s Term Loans B-3 as of such date. These fees are charged to interest expense over the term of the Term Loans B-3 using the effective interest rate method.

The Term Loans B-3 are subject to a 1.00% prepayment premium to the extent the Term Loans B-3 are refinanced, or the terms thereof are amended, in either case, for the purpose of reducing the applicable yield with respect thereto, in each case prior to the first anniversary of the refinancing.

As of June 30, 2013, $298.8 million of the remaining Term Loans (the “Term Loans B-2”) are outstanding. The Term Loans B-2 matures on November 16, 2015. Interest on these Term Loans B-2 is payable monthly at: (i) for LIBOR loans for any interest period, a rate per annum equal to the LIBOR rate as determined by the administrative agent, plus an applicable margin of 4.50% and (ii) for base rate loans, a rate per annum equal to the greater of (x) the prime rate of the administrative agent and (y) the federal funds rate plus one-half of 1.00%, plus an applicable margin of 3.50%. As of June 30, 2013, the entire amount of the Term Loans B-2 consisted of LIBOR loans and the interest rate thereon was 4.70%.

The Term Loans B-2 are payable in quarterly principal installments of $0.4 million on December 31, 2014 and $2.4 million over the payment period between March 31, 2015 and September 30, 2015, with the remainder due on the maturity date of November 16, 2015.

The Company is required to apply a certain portion of its excess cash to the principal amount of the Term Loans on an annual basis. Excess cash under the Company’s Credit Agreement is defined as net income attributable to the Company adjusted for certain cash and non-cash items and is required to be calculated after the end of each year. Required payments, if any are due in March of the subsequent year. The Company made payments related to its excess cash in March 2013 and 2012 of $4.8 million and $6.8 million, respectively. The excess cash payment paid in March 2013 was classified as a current liability as of December 31, 2012.

Revolving Line of Credit

As of June 30, 2013, the Company had aggregate revolving credit commitments of $63.0 million which mature on August 16, 2015. Interest is payable quarterly at (i) for LIBOR loans for any interest period, a rate per annum equal to the LIBOR rate as determined by the administrative agent, plus an applicable margin of 4.00%, 3.75%, 3.50% or 3.25%, based upon the Company’s leverage ratio being within certain defined ranges, and (ii) for base rate loans, a

 

8


Table of Contents

rate per annum equal to the greater of (x) the prime rate of the administrative agent and (y) the federal funds rate plus one-half of 1.00%, plus an applicable margin of 3.00%, 2.75%, 2.50% or 2.25%, based upon the Company’s leverage ratio being within certain defined ranges. Commitment fees are payable quarterly at a rate equal to 0.625% per annum. As of June 30, 2013, the amount outstanding under the Company’s Revolving Line of Credit was $9.0 million bearing an average interest rate of 4.24%. As of June 30, 2013, the Company’s letters of credit against the revolving commitments were $9.2 million.

The Company’s Term Loans and Revolving Line of Credit are guaranteed by the Company’s Parent and substantially all of the Company’s current and future wholly-owned domestic subsidiaries, and secured by their existing and future property and assets, and secured by a pledge of the Company’s capital stock and the capital stock of the Company’s domestic wholly-owned subsidiaries and up to 65% of the capital stock of first-tier foreign subsidiaries. The Company’s Credit Agreement requires the Company to comply on a quarterly basis with certain financial and other covenants, including a maximum total leverage ratio test and an interest coverage ratio test. As of June 30, 2013, the Company was in compliance with all the covenants.

Senior Subordinated Notes

As of June 30, 2013, the outstanding aggregate principal amount related to the Company’s 10.75% Senior Subordinated Notes (the “Notes”) due February 1, 2016, was $176.6 million, net of discount of $0.7 million. Interest is payable semiannually. The Company may redeem some or all of the Notes at the redemption prices (expressed as percentages of principal amount of Notes to be redeemed) set forth below, plus accrued and unpaid interest thereon, if redeemed during the twelve-month period beginning on February 1 of each of the years indicated below:

 

Year

   Percentage  

2013

     101.792

2014 and thereafter

     100.000

If there is a change of control as specified in the indenture, the Company must offer to repurchase the Notes at 101% of their face amount, plus accrued and unpaid interest. The Notes are subordinated to all of the Company’s existing and future senior indebtedness, rank equally with all of the Company’s existing and future senior subordinated indebtedness and rank senior to all of the Company’s existing and future subordinated indebtedness. The Notes are guaranteed on an unsecured senior subordinated basis by each of the Company’s wholly owned subsidiaries that guarantee the Company’s Term Loans and Revolving Line of Credit. The Company’s Notes agreement requires it to comply on a quarterly basis with certain covenants. As of June 30, 2013, the Company was in compliance with all the covenants.

As of June 30, 2013, currently scheduled principal payments of total debt, excluding the effects of the discounts on the term loans and the senior subordinated notes, are as follows (in thousands):

 

2013 (remaining 6 months)

   $ —     

2014

     538   

2015

     392,271   

2016

     177,296   
  

 

 

 

Total

   $ 570,105   
  

 

 

 

Interest expense — The following table presents the components of interest expense (in thousands):

 

     Three Months Ended June 30,     Six Months Ended June 30,  
     2013     2012     2013     2012  

Contractual interest on total debt

   $ 11,013      $ 11,304      $ 21,933      $ 21,544   

Amortization of debt discount and capitalized financing costs

     1,332        1,354        2,122        3,014   

Interest capitalized to property and equipment, net

     (182     (106     (413     (220
  

 

 

   

 

 

   

 

 

   

 

 

 

Total interest expense

   $ 12,163      $ 12,552      $ 23,642      $ 24,338   
  

 

 

   

 

 

   

 

 

   

 

 

 

NOTE 4. DERIVATIVES AND HEDGING ACTIVITIES

Risk Management Objective of Using Derivatives

The Company is exposed to certain risk arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management

 

9


Table of Contents

of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its debt funding and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s investments and borrowings. However, the Company does not use derivatives for trading or speculative purposes and currently does not have any derivatives that are not designated as hedges.

Cash Flow Hedges of Interest Rate Risk

The Company’s objective in using interest rate derivatives is to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. In 2012 the Company entered into an interest rate swap to hedge the variable cash flows associated with existing variable-rate debt. As of June 30, 2013, the Company had one interest rate derivative designated as a cash flow hedge of interest rate risk, with a $200.0 million notional amount, paying fixed interest at 0.287% and maturing on June 30, 2014.

The effective portion of changes in the fair value of a derivative that qualifies and is designated as a cash flow hedge is recorded in accumulated other comprehensive loss and is subsequently reclassified into interest expense as interest payments are made on the Company’s variable-rate debt. The ineffective portion of the change in fair value of this type of derivative is recognized directly in earnings. During the next twelve months, the Company estimates that an additional $0.1 million will be reclassified as an increase to interest expense. As of June 30, 2013, the $0.1 million fair value of this derivative was recorded as “other current liabilities” in the Condensed Consolidated Balance Sheet.

The table below presents the effect of the Company’s derivative financial instruments on the Condensed Consolidated Statement of Operations (in thousands):

 

Derivatives Designated as

Cash Flow Hedges For the

Six Months Ended June 30,

   Amount of Gain or
(Loss) Recognized in
OCI on Derivative
(Effective Portion)
     Location of Gain or
(Loss) Reclassified
From Accumulated
OCI into Income
(Effective portion)
     Amount of Gain or
(Loss) Reclassified
from Accumulated
OCI into Income
(Effective Portion)
     Location of Gain or
(Loss) Recognized in
Income on Derivative
(Ineffective Portion and
Amount Excluded from
Effectiveness Testing)
     Amount of Gain or
(Loss) Recognized in
Income on Derivative
(Ineffective Portion and
Amount Excluded from
Effectiveness Testing)
 
     2013     2012             2013     2012             2013     2012  

Interest Rate Derivatives

                    

Pay-Fixed Swaps

   $ (34   $ 0         Interest expense       $ (42   $ 0         Other Income       $ (43   $ 0   

Credit-risk-related Contingent Features

The Company has agreements with each of its derivative counterparties that contain a provision where the Company could be declared in default on its derivative obligations if repayment of the underlying indebtedness is accelerated by the lender due to the Company’s default on the indebtedness. As of June 30, 2013, the fair value of derivatives in a net liability position, which includes accrued interest but excludes any adjustment for nonperformance risk, related to these agreements was $0.1 million. If the Company had breached any of these provisions as of June 30, 2013, it could have been required to settle its obligations under the agreements at their termination value of $0.1 million.

NOTE 5. FAIR VALUE MEASUREMENTS

Assets and Liabilities Measured at Fair Value on a Recurring Basis

Derivative financial instruments

Currently, the Company uses interest rate swaps to manage its interest rate risk. The valuation of these instruments is determined using widely accepted valuation techniques including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on an expectation of future interest rates (forward curves) derived from observable market interest rate forward curves.

 

10


Table of Contents

The Company incorporates credit valuation adjustments to appropriately reflect both its own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. In adjusting the fair value of its derivative contracts for the effect of nonperformance risk, the Company has considered the impact of netting and any applicable credit enhancements, such as collateral postings, thresholds, mutual puts, and guarantees. In conjunction with the FASB’s fair value measurement guidance, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.

Although the Company has determined that the majority of the inputs used to value its derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by itself and its counterparties. However, as of June 30, 2013, the Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative positions and has determined that the credit valuation adjustments are not significant to the overall valuation of its derivatives. As a result, the Company has determined that its derivative valuations in their entirety are classified in Level 2 of the fair value hierarchy.

The table below presents the Company’s assets and liabilities measured at fair value on a recurring basis as of June 30, 2013, aggregated by the level in the fair value hierarchy within which those measurements fall as of June 30, 2013 and December 31, 2012 (in thousands):

 

    Quoted Prices in
Active  Markets
(Level 1)
    Significant Other
Observable  Inputs
(Level 2)
    Significant
Unobservable  Inputs
(Level 3)
    Total Fair Value  
    June 30,
2013
    December 31,
2012
    June 30,
2013
    December 31,
2012
    June 30,
2013
    December 31,
2012
    June 30,
2013
    December 31,
2012
 

Assets

               

Derivative Financial Instruments

  $ 0      $ 0      $ 0      $ 0      $ 0      $ 0      $ 0      $ 0   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Liabilities

               

Derivative Financial Instruments

  $ 0      $ 0      $ 66      $ 117      $ 0      $ 0      $ 66      $ 117   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis

The Company’s goodwill and other indefinite-lived intangible assets are tested and reviewed annually for impairment during the fourth quarter or whenever there is a significant change in events or circumstances that indicate that the fair value of the asset may be less than the carrying amount of the asset. In addition, the Company’s property and equipment and finite-lived intangibles are assessed for recoverability of the carrying value whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable.

The following table presents the non-financial assets that were measured and recorded at fair value based on Level 3 inputs on a non-recurring basis during the three and six months ended June 30, 2013 (in thousands):

 

     Three and Six Months Ended June 30, 2013  
     Impairment Charge      Fair Value  

Property and equipment

   $ 568       $ —     

Other intangible assets

     10,291         —     
  

 

 

    

 

 

 

Total

   $ 10,859       $ —     
  

 

 

    

 

 

 

Fair Value of Financial Instruments

Financial instruments not measured at fair value on a recurring basis include cash, restricted cash, accounts receivable (net), loan program notes receivable (net), accounts payable, term loans (net), and senior subordinated notes (net). With the exception of financial instruments noted in the following table, the fair value of the Company’s financial instruments approximate carrying value due to their short maturities.

 

11


Table of Contents

The estimated fair value of financial instruments with long-term maturities is as follows:

 

     June 30, 2013      December 31, 2012  
     Carrying
Amount
     Fair Value      Carrying
Amount
     Fair Value  (1)  

Assets

           

Loan program notes receivable, net

   $ 10,675       $ 9,282       $ 11,473       $ 9,606   
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

           

Term loans, net

   $ 381,555       $ 404,120       $ 385,875       $ 402,757   

Senior subordinated notes, net

     176,614         187,956         176,482         181,248   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total liabilities

   $ 558,169       $ 592,076       $ 562,357       $ 584,005   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(1) 

The fair values as of December 31, 2012 have been corrected from amounts previously reported.

The estimated fair value for loan program notes is primarily based on securitization market conditions for similar loans. The Company’s term loans are measured at fair value based on present value methods using credit spreads derived from market data to discount the projected interest and principal payments. The Company’s senior subordinated notes are measured at fair value based on bond-yield data from market trading activity as well as U.S Treasury rates with similar maturities as the senior subordinated notes to discount the projected interest and principal payments. As of June 30, 2013 and December 31, 2012, the estimated fair value of loan program notes receivable, term loans and senior subordinated notes was determined based on Level 3 inputs.

NOTE 6. COMMITMENTS AND CONTINGENCIES

Legal Matters — In a complaint initially filed on July 6, 2011, and amended on August 25, 2011, in Multnomah County Circuit Court in Oregon, 17 former students of one of our previously closed therapeutic boarding school facilities allege claims for intentional and negligent infliction of emotional distress, battery, breach of contract and negligence arising out of their treatment in certain programs of our school. We and our subsidiaries, Aspen Education Group, Inc. (“Aspen”) and Mount Bachelor Educational Center, Inc. (“MBA”), are among the defendants in the pending litigation. The plaintiffs seek a total of $26.0 million in relief. A second and third suit were filed in November 2011 and January 2013, respectively, in Multnomah County Circuit Court in Oregon by 14 former and 13 former students, respectively, also alleging abuse. The plaintiffs seek a total of $23 million in relief in the second suit and a total of $19.5 million in relief in the third suit. We and the other defendants intend to defend vigorously the pending lawsuits. In consultation with counsel and based on our preliminary investigation into the facts alleged, we believe these cases are without merit. However, at this time, we are unable to predict the outcome of the lawsuit, the possible loss or range of loss, if any, after consideration of the extent of insurance coverage associated with the resolution of the lawsuit or any potential effect it may have on us or our operations. On May 10, 2012, Nautilus Insurance Corporation filed a complaint against CRC Health Group Inc. and certain related entities seeking declaratory relief in the federal district court in Portland, Oregon. The Complaint seeks a judicial determination as to whether the Nautilus general and healthcare professional liability insurance policies provide coverage for these suits against MBA and asks the court to enter judgment that the policies are null and void, or alternatively that the policies do not cover these specific lawsuits, and to declare that Nautilus has no duty to defend or indemnify MBA, Aspen or CRC. This litigation with Nautilus Insurance Corporation has been stayed pending resolution of the underlying suits against MBA. In consultation with counsel and based on our preliminary review of the matters alleged, we believe this suit is without merit and we are vigorously defending the matter.

In a complaint filed in August 2011, a suit against our New Life Lodge facility was brought by Kathy Mauk as administrator of the estate of Lindsey Poteet a/k/a Lindsey Richardson, deceased and on behalf of the wrongful death beneficiary of Lindsey Poteet a/k/a Lindsey Richardson, Arwen Richardson, vs. CRC Health Tennessee, Inc. dba New Life Lodge and CRC Health Group, Inc. dba New Life Lodge. The suit alleges negligence and medical malpractice resulting in wrongful death and seeks a total $32.0 million in compensatory and punitive damages. A second suit was brought in December 2012 against our New Life Lodge facility by Charity Comage as administrator of the estate of and on behalf of Savon Kinney, deceased vs CRC Health Tennessee, Inc. dba New Life Lodge and CRC Health Group, Inc. dba New Life Lodge, American Behavioral Consultants, LLC and Holly Liter, APN. The second suit alleges negligence and medical malpractice resulting in the wrongful death and seeking a total $14.5 million in compensatory and punitive damages. American Behavioral Consultants, LLC served as an independent contractor for New Life Lodge and Ms. Holly Liter was an employee of American Behavioral Consultants, LLC. A third suit has been filed against our New Life Lodge by Penny Bryant, mother of Patrick Bryant, deceased, vs. CRC

 

12


Table of Contents

Health Tennessee, Inc. and Jonathan Butler, M.D. This suit was originally filed in 2011 and then dismissed without prejudice in October 2012 and was re-filed in June 2013. This suit alleges negligence resulting in the wrongful death of Patrick Bryant and seeks a total of $13.0 million in compensatory and punitive damages. We intend to defend vigorously these lawsuits. In consultation with counsel and based on our preliminary investigation into the facts alleged, we believe these cases are without merit. Although the Company believes the amounts reserved are adequate based on currently available information, the estimation process involves a considerable amount of judgment by management and the ultimate amounts could vary materially.

Our New Life Lodge facility is currently responding to a civil investigative demand (“CID”) from the Office of the Attorney General of the State of Tennessee inquiring about possible false claims for payment related to services provided to TennCare recipients for the period 2007 to 2011. The United States Department of Justice is participating in this investigation and also has requested information from New Life Lodge. We are cooperating fully with the investigation. Such CIDs are often associated with previously filed qui tam actions, or lawsuits filed under seal under the False Claims Act (“FCA”). Qui tam actions are brought by private plaintiffs suing on behalf of the federal government for alleged FCA violations. The Company firmly believes that any false claims action is without merit. If litigation results, we intend to vigorously defend our position; however, we cannot predict the outcome or timing of such litigation. Although the Company believes that the amounts reserved are adequate based on currently available information, the estimation process involves a considerable amount of judgment by management and the ultimate amounts could vary materially.

We are involved in other litigation and regulatory investigations arising in the ordinary course of business. After consultation with legal counsel, management estimates that these matters will be resolved without material adverse effect on our future financial position or results from operations and cash flows, except as discussed above. As of June 30, 2013 and December 31, 2012, accruals for legal matters totaled $4.4 million and $1.6 million, respectively, and were included in “accrued expenses” in the Condensed Consolidated Balance Sheets.

NOTE 7. RESTRUCTURING

As of June 30, 2013, the Company’s restructuring reserve of $7.5 million consists primarily of future rental payments, net of estimated sublease income. These charges are expected to continue through 2020 and are summarized in the following table (in thousands):

 

     Recovery (1)     Youth     Total  

Total restructuring reserve at December 31, 2012

   $ 1,412      $ 7,882      $ 9,294   

Expenses

     66        323        389   

Cash payments

     (140     (711     (851

Reclassification to accrued expenses

     (1,338     —          (1,338
  

 

 

   

 

 

   

 

 

 

Total restructuring reserve at June 30, 2013

   $ —        $ 7,494      $ 7,494   
  

 

 

   

 

 

   

 

 

 

 

(1) 

The restructuring reserve balance and associated activity represents a purchase accounting liability that was accrued in connection with a 2009 acquisition. This amount was inappropriately included in the restructuring reserve disclosure as of December 31, 2009 and thereafter. As of June 30, 2013 and December 31, 2012, the purchase accounting liability is included in “accrued expenses” in the Condensed Consolidated Balance Sheet and the restructuring reserve table above has been appropriately adjusted.

 

13


Table of Contents

NOTE 8. DISCONTINUED OPERATIONS

The results of operations for those facilities classified as discontinued operations are summarized below (in thousands). The three and six months ended June 30, 2012 reflect the effects of the corrections in Note 1.

 

     Three Months Ended June 30,     Six Months Ended June 30,  
     2013     2012     2013     2012  

Net client service revenues

   $ 36      $ 617      $ 70      $ 1,329   

Operating expenses

     542        1,379        925        3,365   

Interest expense

     —          —          —          (1
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss before income taxes

     (506     (762     (855     (2,037

Loss on disposal of discontinued operations

     17        —          17        —     

Income tax benefit

     (249     (309     (387     (791
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss from discontinued operations

   $ (274   $ (453   $ (485   $ (1,246
  

 

 

   

 

 

   

 

 

   

 

 

 

NOTE 9. SEGMENT INFORMATION

Reportable segments are based upon the Company’s organizational structure, the manner in which the operations are managed and on the level at which the Company’s chief operating decision-maker allocates resources. The Company’s chief operating decision-maker is its Chief Executive Officer.

A summary of the Company’s reportable segments are as follows:

Recovery — The recovery segment specializes in the treatment of chemical dependency and other behavioral health disorders. Services offered in this segment include: inpatient/residential care, partial/day treatment, intensive outpatient groups, therapeutic living/half-way house environments, aftercare centers and detoxification. As of June 30, 2013, the recovery segment operates 30 inpatient, 16 outpatient facilities, and 58 comprehensive treatment centers (“CTCs”) in 21 states.

Youth — The youth segment provides a wide variety of adolescent therapeutic programs through settings and solutions that match individual needs with the appropriate learning and therapeutic environment. Services offered in this segment include boarding schools and experiential outdoor education programs. As of June 30, 2013, the youth segment operates 15 adolescent and young adult programs in 6 states.

Weight management — The weight management segment provides adult and adolescent treatment services for obesity and eating disorders, each a related behavioral disorder. Services offered in this segment include treatment plans through a combination of medical, psychological and social treatment programs. As of June 30, 2013, the weight management segment operates 17 facilities in 8 states, and one in the United Kingdom.

Corporate — In addition to the three reportable segments described above, the Company has activities classified as corporate which represent general and administrative expenses (management, financial, legal, human resources and information systems), and stock-based compensation expense that are not allocated to the segments.

Major Customers — No single customer represented 10% or more of the Company’s total net revenue in any period presented.

Geographic Information — The Company’s business operations are primarily in the United States.

 

14


Table of Contents

Selected financial information for the Company’s reportable segments is presented in the table below (in thousands). The three and six months ended June 30, 2012 reflect the effects of the corrections in Note 1.

 

     Three Months Ended June 30,     Six Months Ended June 30,  
     2013     2012     2013     2012  

Net client service revenues:

        

Recovery

   $ 94,269      $ 88,513      $ 184,944      $ 175,609   

Youth

     17,556        19,823        32,494        36,125   

Weight management

     6,741        6,623        11,701        11,423   

Corporate

     9        18        20        42   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total net client service revenues

   $ 118,575      $ 114,977      $ 229,159      $ 223,199   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income (loss):

        

Recovery

   $ 28,817      $ 28,083      $ 54,708      $ 53,077   

Youth

     (8,958     1,534        (11,586     38   

Weight management

     (1,894     (454     (1,956     (1,023

Corporate

     (11,665     (8,515     (20,868     (17,265
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     6,300        20,648        20,298        34,827   

Interest expense

     (12,163     (12,552     (23,642     (24,338

Other income

     241        251        503        494   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

   $ (5,622   $ 8,347      $ (2,841   $ 10,983   
  

 

 

   

 

 

   

 

 

   

 

 

 

NOTE 10. ASSET IMPAIRMENTS AND SUBSEQUENT EVENTS

In early July 2013, the Company began the process of closing five of its Youth Division facilities and one of its Weight Management Division facilities. As a result of these actions, the Company recorded non-cash impairment charges related to property and equipment and other intangible assets in the amount of $0.6 million and $6.6 million, respectively, in the three months ended June 30, 2013. These charges are included in “asset impairments” in the Condensed Consolidated Statements of Operations. The Company expects the closure process for each of these facilities to be completed by September 30, 2013. Also, the Company anticipates recording employee severance charges of approximately $0.5 million and lease termination charges in the range of $9.0 to $10.0 million, respectively, in the three months ending September 30, 2013 related to these facility closures.

On August 1, 2013, the Company sold the Oakley School, a Youth Division facility. In connection with this sale, the Company recorded a $3.7 million charge related to other intangible assets in the three months ended June 30, 2013. This non-cash impairment charge is included in “asset impairments” in the Condensed Consolidated Statements of Operations.

These seven facilities and their associated results of operations (including asset impairments) will be reclassified to discontinued operations in the three and nine months ended September 30, 2013.

NOTE 11. CONDENSED CONSOLIDATING FINANCIAL INFORMATION

As of June 30, 2013, the Company had $176.6 million aggregate principal amount of the Notes outstanding. The Notes are fully and unconditionally guaranteed, jointly and severally on an unsecured senior subordinated basis, by the Company’s 100% owned subsidiaries.

The following supplemental tables present condensed consolidating balance sheets for the Company and its subsidiary guarantors as of June 30, 2013 and December 31, 2012; the condensed consolidating statements of operations for the three and six months ended June 30, 2013 and 2012; the condensed consolidated statements of comprehensive income (loss) for the three and six months ended June 30, 2013 (total comprehensive income was the same as net income for the respective three and six months ended June 30, 2012); and the condensed consolidating statements of cash flows for the six months ended June 30, 2013 and 2012. These supplemental tables reflect the effects of the corrections to our Condensed Consolidated Financial Statements in Note 1.

 

15


Table of Contents

Condensed Consolidating Balance Sheet as of June 30, 2013

(In thousands)

(Unaudited)

 

     CRC Health
Corporation
     Subsidiary
Guarantors
     Eliminations     Consolidated  

Assets

          

Current assets:

          

Cash and cash equivalents

   $ —         $ 11,040       $ —        $ 11,040   

Restricted cash

     280         —           —          280   

Accounts receivable, net

     —           39,331         —          39,331   

Prepaid expenses

     3,951         3,479         —          7,430   

Other current assets

     1,176         1,422         —          2,598   

Income taxes receivable

     3,094         —           —          3,094   

Deferred income taxes

     6,352         —           —          6,352   

Current assets of discontinued operations

     —           3,135         —          3,135   
  

 

 

    

 

 

    

 

 

   

 

 

 

Total current assets

     14,853         58,407         —          73,260   

Property and equipment, net

     8,194         123,212         —          131,406   

Goodwill

     —           519,093         —          519,093   

Other intangible assets, net

     —           281,079         —          281,079   

Other assets, net

     17,766         539         —          18,305   

Investment in subsidiaries

     935,682         —           (935,682     —     
  

 

 

    

 

 

    

 

 

   

 

 

 

Total assets

   $ 976,495       $ 982,330       $ (935,682   $ 1,023,143   
  

 

 

    

 

 

    

 

 

   

 

 

 

Liabilities and stockholder’s equity

          

Current liabilities:

          

Accounts payable

   $ 6,276       $ 1,231       $ —        $ 7,507   

Accrued liabilities

     25,229         15,972         —          41,201   

Other current liabilities

     967         14,505         —          15,472   

Current liabilities of discontinued operations

     —           2,287         —          2,287   
  

 

 

    

 

 

    

 

 

   

 

 

 

Total current liabilities

     32,472         33,995         —          66,467   

Long-term debt

     567,174         —           —          567,174   

Other long-term liabilities

     1,827         6,815         —          8,642   

Long-term liabilities of discontinued operations

     —           5,838         —          5,838   

Deferred income taxes

     107,310         —           —          107,310   
  

 

 

    

 

 

    

 

 

   

 

 

 

Total liabilities

     708,783         46,648         —          755,431   

Total stockholder’s equity

     267,712         935,682         (935,682     267,712   
  

 

 

    

 

 

    

 

 

   

 

 

 

Total liabilities and stockholder’s equity

   $ 976,495       $ 982,330       $ (935,682   $ 1,023,143   
  

 

 

    

 

 

    

 

 

   

 

 

 

 

16


Table of Contents

Condensed Consolidating Balance Sheet as of December 31, 2012

(In thousands)

(Unaudited)

 

     CRC Health
Corporation
     Subsidiary
Guarantors
     Eliminations     Consolidated  

Assets

          

Current assets:

          

Cash and cash equivalents

   $ —         $ 19,058       $ —        $ 19,058   

Restricted cash

     364         —           —          364   

Accounts receivable, net

     —           36,737         —          36,737   

Prepaid expenses

     1,830         2,951         —          4,781   

Other current assets

     1,184         1,407         —          2,591   

Income taxes receivable

     1,109         —           —          1,109   

Deferred income taxes

     6,352         —           —          6,352   

Current assets of discontinued operations

     —           2,759         —          2,759   
  

 

 

    

 

 

    

 

 

   

 

 

 

Total current assets

     10,839         62,912         —          73,751   

Property and equipment, net

     8,578         121,803         —          130,381   

Goodwill

     —           518,953         —          518,953   

Other intangible assets, net

     —           294,085         —          294,085   

Other assets, net

     19,905         491         —          20,396   

Investment in subsidiaries

     957,075         —           (957,075     —     
  

 

 

    

 

 

    

 

 

   

 

 

 

Total assets

   $ 996,397       $ 998,244       $ (957,075   $ 1,037,566   
  

 

 

    

 

 

    

 

 

   

 

 

 

Liabilities and stockholder’s equity

          

Current liabilities:

          

Accounts payable

   $ 5,887       $ 914       $ —        $ 6,801   

Accrued liabilities

     21,843         14,623         —          36,466   

Current portion of long-term debt

     4,822         18         —          4,840   

Other current liabilities

     1,143         9,943         —          11,086   

Current liabilities of discontinued operations

     —           2,372         —          2,372   
  

 

 

    

 

 

    

 

 

   

 

 

 

Total current liabilities

     33,695         27,870         —          61,565   

Long-term debt

     584,535         —           —          584,535   

Other long-term liabilities

     1,716         7,024         —          8,740   

Long-term liabilities of discontinued operations

     —           6,275         —          6,275   

Deferred income taxes

     107,289         —           —          107,289   
  

 

 

    

 

 

    

 

 

   

 

 

 

Total liabilities

     727,235         41,169         —          768,404   
  

 

 

    

 

 

    

 

 

   

 

 

 

Total stockholder’s equity

     269,162         957,075         (957,075     269,162   

Total liabilities and stockholder’s equity

   $ 996,397       $ 998,244       $ (957,075   $ 1,037,566   
  

 

 

    

 

 

    

 

 

   

 

 

 

 

17


Table of Contents

Condensed Consolidating Statements of Operations

For the Three Months Ended June 30, 2013

(In thousands)

(Unaudited)

 

     CRC Health
Corporation
    Subsidiary
Guarantors
    Eliminations     Consolidated  

Net revenues:

        

Net client service revenues

   $ 9      $ 118,566      $ —        $ 118,575   

Management fee revenues

     21,326        —          (21,326     —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Total net revenues

     21,335        118,566        (21,326     118,575   

Operating expenses:

        

Salaries and benefits

     7,587        49,262        —          56,849   

Facilities and other operating costs

     2,980        34,404        —          37,384   

Provision for doubtful accounts

     —          1,851        —          1,851   

Depreciation and amortization

     1,107        4,225        —          5,332   

Asset impairments

     —          10,859        —          10,859   

Management fee expense

     —          21,326        (21,326     —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     11,674        121,927        (21,326     112,275   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     9,661        (3,361     —          6,300   

Interest expense

     (12,163     —          —          (12,163

Other income

     236        5        —          241   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

     (2,266     (3,356     —          (5,622

Income tax expense

     (925     (1,370     —          (2,295

Equity in income of subsidiaries, net of tax

     (2,260     —          2,260        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss from continuing operations

     (3,601     (1,986     2,260        (3,327

Loss from discontinued operations, net of tax

     —          (274     —          (274
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

   $ (3,601   $ (2,260   $ 2,260      $ (3,601
  

 

 

   

 

 

   

 

 

   

 

 

 

 

18


Table of Contents

Condensed Consolidating Statements of Operations

For the Three Months Ended June 30, 2012

(In thousands)

(Unaudited)

 

     CRC Health
Corporation
    Subsidiary
Guarantors
    Eliminations     Consolidated  

Net revenues:

        

Net client service revenues

   $ 18      $ 114,959      $  —        $ 114,977   

Management fee revenues

     20,813        —          (20,813     —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Total net revenues

     20,831        114,959        (20,813     114,977   
        

Operating expenses:

        

Salaries and benefits

     6,722        47,863        —          54,585   

Facilities and other operating costs

     720        32,532        —          33,252   

Provision for doubtful accounts

     —          1,465        —          1,465   

Depreciation and amortization

     1,091        3,936        —          5,027   

Management fee expense

     —          20,813        (20,813     —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     8,533        106,609        (20,813     94,329   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     12,298        8,350        —          20,648   

Interest expense

     (12,552     —          —          (12,552

Other income

     248        3        —          251   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

     (6     8,353        —          8,347   

Income tax expense

     (3     3,503        —          3,500   

Equity in income of subsidiaries, net of tax

     4,397        —          (4,397     —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations

     4,394        4,850        (4,397     4,847   

Loss from discontinued operations, net of tax

     —          (453     —          (453
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 4,394      $ 4,397      $ (4,397   $ 4,394   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

19


Table of Contents

Condensed Consolidating Statements of Operations

For the Six Months Ended June 30, 2013

(In thousands)

(Unaudited)

 

     CRC Health
Corporation
    Subsidiary
Guarantors
    Eliminations     Consolidated  

Net revenues:

        

Net client service revenues

   $ 20      $ 229,139      $ —        $ 229,159   

Management fee revenues

     42,046        —          (42,046     —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Total net revenues

     42,066        229,139        (42,046     229,159   

Operating expenses:

        

Salaries and benefits

     15,105        97,712        —          112,817   

Facilities and other operating costs

     3,568        67,404        —          70,972   

Provision for doubtful accounts

     —          4,026        —          4,026   

Depreciation and amortization

     2,215        7,972        —          10,187   

Asset impairments

     —          10,859        —          10,859   

Management fee expense

     —          42,046        (42,046     —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     20,888        230,019        (42,046     208,861   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     21,178        (880     —          20,298   

Interest expense

     (23,642     —          —          (23,642

Other income

     498        5        —          503   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

     (1,966     (875     —          (2,841

Income tax expense

     (769     (343     —          (1,112

Equity in income of subsidiaries, net of tax

     (1,017     —          1,017        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss from continuing operations

     (2,214     (532     1,017        (1,729

Loss from discontinued operations, net of tax

     —          (485     —          (485
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

   $ (2,214   $ (1,017   $ 1,017      $ (2,214
  

 

 

   

 

 

   

 

 

   

 

 

 

 

20


Table of Contents

Condensed Consolidating Statements of Operations

For the Six Months Ended June 30, 2012

(In thousands)

(Unaudited)

 

     CRC Health
Corporation
    Subsidiary
Guarantors
    Eliminations     Consolidated  

Net revenues:

        

Net client service revenues

   $ 39      $ 223,160      $ —        $ 223,199   

Management fee revenues

     42,287        —          (42,287     —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Total net revenues

     42,326        223,160        (42,287     223,199   
        

Operating expenses:

        

Salaries and benefits

     13,765        95,408        —          109,173   

Facilities and other operating costs

     1,366        64,104        —          65,470   

Provision for doubtful accounts

     —          3,808        —          3,808   

Depreciation and amortization

     2,175        7,746        —          9,921   

Management fee expense

     —          42,287        (42,287     —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     17,306        213,353        (42,287     188,372   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     25,020        9,807        —          34,827   

Interest expense

     (24,338     —          —          (24,338

Other income

     487        7        —          494   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations before income taxes

     1,169        9,814        —          10,983   

Income tax expense

     498        4,186        —          4,684   

Equity in income of subsidiaries, net of tax

     4,382        —          (4,382     —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations

     5,053        5,628        (4,382     6,299   

Loss from discontinued operations, net of tax

     —          (1,246     —          (1,246
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 5,053      $ 4,382      $ (4,382   $ 5,053   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

21


Table of Contents

Condensed Consolidating Statement of Comprehensive Income (Loss)

For the Three Months Ended June 30, 2013

(In thousands)

(Unaudited)

 

    CRC Health
Corporation
    Subsidiary
Guarantors
    Eliminations     Consolidated  

Net loss

  $ (3,601   $ (2,260   $ 2,260      $ (3,601

Other comprehensive income:

       

Net change in unrealized loss on cash flow hedges (net of tax of $5)

    7        —          —          7   
 

 

 

   

 

 

   

 

 

   

 

 

 

Total comprehensive loss

  $ (3,594   $ (2,260   $ 2,260      $ (3,594
 

 

 

   

 

 

   

 

 

   

 

 

 

 

22


Table of Contents

Condensed Consolidating Statement of Comprehensive Income (Loss)

For the Six Months Ended June 30, 2013

(In thousands)

(Unaudited)

 

    CRC Health
Corporation
    Subsidiary
Guarantors
    Eliminations     Consolidated  

Net loss

  $ (2,214   $ (1,017   $ 1,017      $ (2,214

Other comprehensive income:

       

Net change in unrealized loss on cash flow hedges (net of tax of $21)

    31        —          —          31   
 

 

 

   

 

 

   

 

 

   

 

 

 

Total comprehensive loss

  $ (2,183   $ (1,017   $ 1,017      $ (2,183
 

 

 

   

 

 

   

 

 

   

 

 

 

 

23


Table of Contents

Condensed Consolidating Statements of Cash Flows

For the Six Months Ended June 30, 2013

(In thousands)

(Unaudited)

 

     CRC Health
Corporation
    Subsidiary
Guarantors
    Eliminations      Consolidated  

Cash flows from operating activities:

         

Net cash provided by operating activities

   $ 5,210      $ 20,158      $ —         $ 25,368   
  

 

 

   

 

 

   

 

 

    

 

 

 

Cash flows from investing activities:

         

Additions of property and equipment

     (2,450     (6,982     —           (9,432

Proceeds from the sale of property and equipment

     —          36        —           36   

Acquisition of business, net of cash acquired

     (140     —          —           (140
  

 

 

   

 

 

   

 

 

    

 

 

 

Net cash used in investing activities

     (2,590     (6,946     —           (9,536
  

 

 

   

 

 

   

 

 

    

 

 

 

Cash flows from financing activities:

         

Intercompany transfers

     21,033        (21,033     —           —     

Repayment of long-term debt

     (4,822     (197     —           (5,019

Repayments on revolving line of credit

     (17,995     —          —           (17,995

Capital contributed to Parent

     (599     —          —           (599

Capitalized financing costs

     (217     —          —           (217

Other financing activities

     (20     —          —           (20
  

 

 

   

 

 

   

 

 

    

 

 

 

Net cash used in financing activities

     (2,620     (21,230     —           (23,850
  

 

 

   

 

 

   

 

 

    

 

 

 

Net decrease in cash and cash equivalents

     —          (8,018     —           (8,018

Cash and cash equivalents — beginning of period

     —          19,058        —           19,058   
  

 

 

   

 

 

   

 

 

    

 

 

 

Cash and cash equivalents — end of period

   $ —        $ 11,040      $ —         $ 11,040   
  

 

 

   

 

 

   

 

 

    

 

 

 

 

24


Table of Contents

Condensed Consolidating Statements of Cash Flows

For the Six Months Ended June 30, 2012

(In thousands)

(Unaudited)

 

     CRC Health
Corporation
    Subsidiary
Guarantors
    Eliminations      Consolidated  

Cash flows from operating activities:

         

Net cash provided by operating activities

   $ 12,498      $ 20,090      $ —         $ 32,588   
  

 

 

   

 

 

   

 

 

    

 

 

 

Cash flows from investing activities:

         

Additions of property and equipment

     (1,917     (5,424     —           (7,341

Other investing activities

     (68     39        —           (29
  

 

 

   

 

 

   

 

 

    

 

 

 

Net cash used in investing activities

     (1,985     (5,385     —           (7,370
  

 

 

   

 

 

   

 

 

    

 

 

 

Cash flows from financing activities:

         

Intercompany transfers

     830        (830     —           —     

Borrowings under long-term debt

     84,096        —          —           84,096   

Repayment of long-term debt

     (87,638     (461     —           (88,099

Borrowings on revolving line of credit

     18,000        —          —           18,000   

Repayments on revolving line of credit

     (13,505     —          —           (13,505

Capital contributed to Parent

     (9,524     —          —           (9,524

Capitalized financing costs

     (2,772     —          —           (2,772
  

 

 

   

 

 

   

 

 

    

 

 

 

Net cash used in financing activities

     (10,513     (1,291     —           (11,804
  

 

 

   

 

 

   

 

 

    

 

 

 

Net increase in cash and cash equivalents

     —          13,414        —           13,414   

Cash and cash equivalents — beginning of period

     —          10,183        —           10,183   
  

 

 

   

 

 

   

 

 

    

 

 

 

Cash and cash equivalents — end of period

   $ —        $ 23,597      $ —         $ 23,597   
  

 

 

   

 

 

   

 

 

    

 

 

 

 

 

25


Table of Contents
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion should be read in conjunction with the Unaudited Condensed Consolidated Financial Statements and the related notes that appear elsewhere in this Quarterly Report. Unless the context otherwise requires, in this management’s discussion and analysis of financial condition and results of operations, the terms “our company,” “we,” “us,” “the Company” and “our” refer to CRC Health Corporation and its consolidated subsidiaries.

OVERVIEW

We are a leading provider of treatment services related to substance abuse, troubled youth, and other addiction diseases and behavioral disorders. We deliver our services through our three divisions: recovery, youth and weight management. Our recovery division provides substance abuse and behavioral disorder treatment services through our residential treatment facilities and outpatient treatment clinics. Our youth division provides therapeutic educational programs to underachieving young people through residential schools and outdoor programs. Our weight management division provides treatment services through adolescent and adult weight management programs as well as eating disorder facilities.

As of June 30, 2013 our recovery division, operated 30 inpatient, 16 outpatient facilities, and 58 comprehensive treatment centers (“CTCs”) in 21 states. Our youth division operated 15 adolescent and young adult programs in 6 states. Our weight management division operated 17 facilities in 8 states, and one in the United Kingdom.

We had 2,011 and 1,938 available beds in our residential and extended care facilities as of June 30, 2013 and December 31, 2012, respectively.

The three and six month periods ended June 30, 2012 reflect the effects of the corrections in Note 1—Overview and Basis of Presentation of Notes to Condensed Consolidated Financial Statements.

EXECUTIVE SUMMARY

During the three months ended June 30, 2013 we generated $118.6 million in net client service revenues, an increase of $3.6 million as compared to the three months ended June 30, 2012, this increase was primarily due to increases of $5.8 million and $0.1 million in our recovery and weight management divisions, respectively, offset by a decrease of $2.3 million in our youth division. During the three months ended June 30, 2013, operating income decreased by $14.3 million, or 69.5%, as compared to the three months ended June 30, 2012, primarily due to a decrease of $10.5 million in our youth division, a decrease of $1.4 million in our weight management division, and a decrease of $3.2 million in corporate, offset by an increase of $0.7 million in our recovery division.

During the six months ended June 30, 2013 we generated $229.2 million in net client service revenues, an increase of $6.0 million as compared to the six months ended June 30, 2012, this increase was primarily due to increases of $9.3 million and $0.3 million in our recovery and weight management divisions, respectively, offset by a decrease of $3.6 million in our youth division. During the six months ended June 30, 2013, operating income decreased by $14.5 million, or 41.7%, as compared to the six months ended June 30, 2012, primarily due to a decrease of $11.6 million in our youth division, a decrease of $3.6 million in corporate, and a decrease of $0.9 million in our weight management division, offset by an increase of $1.6 million in our recovery division.

The following table presents the sources of consolidated net client service revenues as a percentage of revenue:

 

     Three Months Ended June 30,     Six Months Ended June 30,  
     2013     2012     2013     2012  

Private

     53     57     53     56

Commercial

     25     23     25     23

Government

     22     20     22     21
  

 

 

   

 

 

   

 

 

   

 

 

 

Total

     100     100     100     100
  

 

 

   

 

 

   

 

 

   

 

 

 

 

26


Table of Contents

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

General

The accompanying discussion and analysis of our financial condition and results of operations are based on our unaudited condensed consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles of the United States. The preparation of these financial statements requires us to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, net revenue and expenses. We have based our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Our senior management has reviewed our critical accounting policies and their application in the preparation of our financial statements and related disclosures and discussed the development, selection and disclosure of significant estimates. To the extent that actual results differ from those estimates, our future results of operations may be affected. We believe that there have not been any significant changes during the six months ended June 30, 2013 to the items that we have previously reported in our critical accounting policies in management’s discussion and analysis of financial condition and results of operations for the year ended December 31, 2012 in our Annual Report on Form 10-K.

RESULTS OF OPERATIONS

The following table presents our results of operations (in thousands):

 

     Three Months Ended June 30,     Six Months Ended June 30,  
     2013     2012     2013     2012  

Net client service revenues:

        

Recovery

   $ 94,269      $ 88,513      $ 184,944      $ 175,609   

Youth

     17,556        19,823        32,494        36,125   

Weight management

     6,741        6,623        11,701        11,423   

Corporate

     9        18        20        42   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total net client service revenues

     118,575        114,977        229,159        223,199   

Operating expenses:

        

Recovery

     65,452        60,430        130,236        122,532   

Youth

     26,514        18,289        44,080        36,087   

Weight management

     8,635        7,077        13,657        12,446   

Corporate

     11,674        8,533        20,888        17,307   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     112,275        94,329        208,861        188,372   

Operating income (loss):

        

Recovery

     28,817        28,083        54,708        53,077   

Youth

     (8,958     1,534        (11,586     38   

Weight management

     (1,894     (454     (1,956     (1,023

Corporate

     (11,665     (8,515     (20,868     (17,265
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     6,300        20,648        20,298        34,827   

Interest expense

     (12,163     (12,552     (23,642     (24,338

Other income

     241        251        503        494   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

     (5,622     8,347        (2,841     10,983   

Income tax expense (benefit)

     (2,295     3,500        (1,112     4,684   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations, net of tax

     (3,327     4,847        (1,729     6,299   

Loss from discontinued operations, net of tax

     (274     (453     (485     (1,246
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ (3,601   $ 4,394      $ (2,214   $ 5,053   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

27


Table of Contents

The following table compares total facility statistics:

 

     Three Months Ended June 30,      Six Months Ended June 30,  
     2013      2012      2013      2012  

Recovery

           

Residential and outpatient facilities

           

Net client service revenues (in thousands)

   $ 58,732       $ 55,109       $ 114,946       $ 109,874   

Patient days

     150,049         141,065         292,981         280,903   

Net client service revenues per patient day

   $ 391.42       $ 390.66       $ 392.33       $ 391.15   

CTCs

           

Net client service revenues (in thousands)

   $ 35,537       $ 33,404       $ 69,999       $ 65,735   

Patient days

     2,722,713         2,563,856         5,349,897         5,069,827   

Net client service revenues per patient day

   $ 13.05       $ 13.03       $ 13.08       $ 12.97   

Youth

           

Residential facilities

           

Net client service revenues (in thousands)

   $ 9,923       $ 12,207       $ 19,408       $ 23,117   

Patient days

     31,847         41,295         62,604         79,869   

Net client service revenues per patient day

   $ 311.58       $ 295.60       $ 310.01       $ 289.44   

Outdoor programs

           

Net client service revenues (in thousands)

   $ 7,633       $ 7,616       $ 13,086       $ 13,008   

Patient days

     16,351         15,441         27,887         26,689   

Net client service revenues per patient day

   $ 466.82       $ 493.23       $ 469.25       $ 487.39   

Weight Management

           

Net client service revenues (in thousands)

   $ 6,741       $ 6,623       $ 11,701       $ 11,423   

Patient days

     17,833         20,316         29,920         32,283   

Net client service revenues per patient day

   $ 378.01       $ 326.00       $ 391.08       $ 353.84   

Three Months Ended June 30, 2013 Compared to Three Months Ended June 30, 2012

Recovery

Net client service revenues increased $5.8 million, or 6.5%, primarily due to a $3.6 million increase in our residential facilities and a $2.1 million increase in our CTC facilities. The increase in revenues at our residential facilities was driven in part by the re-opening of New Life Lodge in April 2012, and certain bed expansions at two residential facilities in Pennsylvania. The increase in revenues at our CTC facilities was primarily due to increased patient days at our facilities driven by marketing programs and clinically appropriate retention efforts.

Operating expenses increased $5.0 million, or 8.3%, primarily due to a $3.2 million increase related to our residential facilities, a $1.3 million increase related to our CTC facilities and a $0.5 million increase in direct administrative cost related to the recovery division. The increased operating expenses at our residential facilities were primarily due to increases in salaries, wages and benefits, outside services and other operating costs associated with increased patient days. The increased operating expenses at our CTC facilities was primarily due to increased marketing activities and employee salaries, wages and benefits associated with increased patient days.

Youth

Net client service revenues decreased by $2.3 million, or 11.4%, primarily due to a decrease in patient days at our residential facilities.

Operating expenses increased $8.2 million, or 45.0%, due to $8.0 million of asset impairments recorded in the second quarter of fiscal 2013.

Weight Management

Net client service revenues increased by $0.1 million, or 1.8%, primarily due to increases in patient days in our adult residential weight loss facility offset by a decrease in patient days in our adolescent weight loss programs.

 

28


Table of Contents

Operating expenses increased $1.6 million, or 22.0%, primarily due to $2.9 million of asset impairments recorded in the second quarter of fiscal 2013 offset by a decrease in salaries, wages and benefits.

Corporate

Operating expenses increased $3.1 million, or 36.8%, primarily due to a $2.5 million increase in legal expenses in the second quarter of fiscal 2013 and a $0.7 million increase in salaries, wages and benefits.

Six Months Ended June 30, 2013 Compared to Six Months Ended June 30, 2012

Recovery

Net client service revenues increased $9.3 million, or 5.3%, primarily due to a $5.1 million increase in our residential facilities and a $4.3 million increase in our CTC facilities. The increase in revenues at our residential facilities was driven in part by the re-opening of New Life Lodge in April 2012, and certain bed expansions at two residential facilities in Pennsylvania. The increase in revenues at our CTC facilities was primarily due to increased patient days at our facilities driven by marketing programs and clinically appropriate retention efforts.

Operating expenses increased $7.7 million, or 6.3%, primarily due to a $4.8 million increase related to our residential facilities, a $2.5 million increase related to our CTC facilities and a $0.4 million increase in direct administrative cost in the recovery division. The increased operating expenses at our residential facilities were primarily due to increases in salaries, wages and benefits, outside services and other operating costs associated with increased patient days. The increased operating expenses at our CTC facilities was primarily due to increased marketing activities and employee salaries, wages and benefits associated with increased patient days.

Youth

Net client service revenues decreased by $3.6 million, or 10.1%, primarily due to a decrease in patient days at our residential facilities.

Operating expenses increased $8.0 million, or 22.1%, due to $8.0 million of asset impairments recorded in the second quarter of fiscal 2013.

Weight Management

Net client service revenues increased by $0.3 million, or 2.4%, primarily due to increases in patient days in our adult residential weight loss facility offset by a decrease in patient days in our adolescent weight loss programs.

Operating expenses increased $1.2 million, or 9.7%, primarily due to $2.9 million of asset impairments recorded in the second quarter of fiscal 2013 offset by a decrease in salaries, wages and benefits.

Corporate

Operating expenses increased $3.6 million, or 20.7%, primarily due to a $2.5 million increase in legal expenses in the second quarter of fiscal 2013 and a $1.1 million increase in salaries, wages and benefits.

Interest expense

The following table presents the components of interest expense (in thousands):

 

     Three Months Ended June 30,     Six Months Ended June 30,  
     2013     2012     2013     2012  

Contractual interest on total debt

   $ 11,013      $ 11,304      $ 21,933      $ 21,544   

Amortization of debt discount and capitalized financing costs

     1,332        1,354        2,122        3,014   

Interest capitalized to property and equipment, net

     (182     (106     (413     (220
  

 

 

   

 

 

   

 

 

   

 

 

 

Total interest expense

   $ 12,163      $ 12,552      $ 23,642      $ 24,338   
  

 

 

   

 

 

   

 

 

   

 

 

 

Contractual interest on total debt decreased by $0.3 million during the three months ended June 30, 2013 as compared to the same period in the prior year, primarily due to a lower Term Loan balance and interest rate during the three months ended June 30, 2013 when compared to the three months ended June 30, 2012.

Contractual interest on total debt increased by $0.4 million for the six months ended June 30, 2013, as compared to the same period in the prior year, primarily due to the fact that a portion of the Company’s term loans were refinanced in March 2012 at a higher principal balance. This refinancing event also resulted in the acceleration of approximately $0.7 million of debt discount and capitalized financing costs amortization which was recorded during the six months ended June 30, 2012.

 

29


Table of Contents

Income tax expense

We calculate our income tax expense for interim periods by applying the full year’s estimated effective tax rate to our financial statements for interim periods.

For the three months ended June 30, 2013 and 2012, our tax benefit and expense on continuing operations was $2.3 million and $3.5 million, respectively, representing an effective tax rate of 40.8% and 41.9%. The change in the effective tax rate is primarily due to the decreases to state tax expense and interest expense related to uncertain tax positions.

For the six months ended June 30, 2013 and 2012, our tax benefit and expense on continuing operations was $1.1 million and $4.7 million, respectively, representing an effective tax rate of 39.1% and 42.6%. The change in the effective tax rate is due primarily to the decreases to state tax expense and interest expense related to uncertain tax positions.

Loss from discontinued operations, net of tax

During the three and six months ended June 30, 2013, loss from discontinued operations, net of tax, decreased by $0.2 million and $0.8 million, respectively, as compared to the same period in the prior year. The decrease is due to discontinuing two entities in 2012 and none in 2013.

Sources and Uses of Cash

Our principal sources of liquidity for operating activities are payments from self-pay patients, commercial payors and government programs for treatment services, and our revolving line of credit. We receive cash from our self-payors in advance, upon completion of treatment, or over time as accounts receivable are collected. Cash from commercial payors and government programs is typically received upon the collection of accounts receivable, which are generated upon delivery of treatment services.

 

     Six Months Ended June 30,  
     2013     2012  
     (In thousands)  

Net cash provided by operating activities

   $ 25,368      $ 32,588   

Net cash used in investing activities

     (9,536     (7,370

Net cash used in financing activities

     (23,850     (11,804
  

 

 

   

 

 

 

Net increase (decrease) in cash

   $ (8,018   $ 13,414   
  

 

 

   

 

 

 

Cash provided by operating activities was $25.4 million for the six months ended June 30, 2013, as compared to $32.6 million during the same period in 2012. The decrease of $7.2 million is primarily due to an increase in accounts receivable related to increased revenues and an increase in prepaid expenses related to the timing of business insurance renewals.

Cash used in investing activities was $9.5 million for the six months ended June 30, 2013, as compared to $7.4 million during the same period of 2012. The increase of $2.1 million is primarily due to an increase in capital expenditures.

Cash used in financing activities was $23.9 million for the six months ended June 30, 2013, as compared to $11.8 million during the same period in 2012. The increase of $12.1 million is due to an increase in net repayments on long-term debt and Revolving Line of Credit , partially offset by a decrease in capitalized financing costs and cash distributed to parent. The decrease in capital distributed to parent was related to a year over year decrease in principal payments made by our parent company on its debt.

Financing and Liquidity

A significant portion of our cash generated from operations goes to service our debt and maintain our facilities. We anticipate that cash generated by current operations, funds available under the revolving portion of our senior secured credit facility and existing cash and cash equivalents will be sufficient to meet working capital requirements, service our debt and finance capital expenditures over the next 12 months.

 

30


Table of Contents

Credit Agreements — Refer to Note 3 to Unaudited Condensed Consolidated Financial Statements for further discussion about our long-term borrowing arrangements.

Under the terms of our borrowing arrangements, we are required to comply with various covenants, including the maintenance of certain financial ratios, the calculations of which are based on Adjusted EBITDA, as defined in our credit agreements. As of June 30, 2013, we were in compliance with all such covenants. A breach of these could result in a default under our credit facilities and in our being unable to borrow additional amounts under our revolving credit facility. If an event of default occurs, the lenders could elect to declare all amounts borrowed under our credit facilities to be immediately due and payable and the lenders under our term loans and revolving credit facility could proceed against the collateral securing the indebtedness.

The computation of Adjusted EBITDA is provided below to provide an understanding of the impact that Adjusted EBITDA has on our ability to comply with certain covenants in our borrowing arrangements that are tied to these measures and to borrow under the credit facility. Adjusted EBITDA should not be considered as an alternative to net income (loss) or cash flows from operating activities (which are determined in accordance with GAAP) and is not being presented as an indicator of operating performance or a measure of liquidity. Other companies may define Adjusted EBITDA differently and, as a result, such measures may not be comparable to our Adjusted EBITDA.

The following table reconciles our net income (loss) to our Adjusted EBITDA for the three and six months ended June 30, 2013 and 2012 (in thousands):

 

     Three Months Ended June 30,      Six Months Ended June 30,  
     2013     2012      2013     2012  

Net Income (Loss) Attributable to CRC Health Corporation:

   $ (3,601   $ 4,394       $ (2,214   $ 5,053   

Depreciation and amortization (1) 

     5,332        5,079         10,187        10,008   

Income tax expense (benefit) (1) 

     (2,545     3,191         (1,499     3,892   

Interest expense

     12,163        12,552         23,642        24,338   
  

 

 

   

 

 

    

 

 

   

 

 

 

EBITDA

     11,349        25,216         30,116        43,291   

Adjustments to EBITDA:

         

Discontinued operations

     381        559         603        1,187   

Asset impairments (1) 

     10,859        —           10,859        —     

Non-impairment restructuring activities (1) 

     218        212         384        930   

Stock-based compensation expense

     774        531         1,332        1,016   

Foreign exchange translation

     (1     1         33        (28

Loss on disposal of property and equipment (1) 

     98        337         190        418   

Management fees

     600        559         1,200        1,134   

Non-recurring legal costs

     2,916        496         3,474        812   

Debt costs

     106        69         167        177   

Other non-cash charges and non-recurring costs

     —          242         —          237   
  

 

 

   

 

 

    

 

 

   

 

 

 

Total adjustments to EBITDA

     15,951        3,006         18,242        5,883   
  

 

 

   

 

 

    

 

 

   

 

 

 

Adjusted EBITDA

   $ 27,300      $ 28,222       $ 48,358      $ 49,174   
  

 

 

   

 

 

    

 

 

   

 

 

 

 

(1) 

Includes amounts related to both continuing operations and discontinued operations.

Off-Balance Sheet Obligations

As of June 30, 2013, our off-balance sheet obligations consisted of $9.2 million in letters of credit and $0.2 million in loan purchase commitments related to our Loan Program.

 

31


Table of Contents

Obligations and Commitments

There were no material changes in our contractual obligations during the six months ended June 30, 2013 compared to the contractual obligations table included in our Annual Report on Form 10-K for the year ended December 31, 2012.

 

Item 3. Quantitative and Qualitative Disclosure about Market Risk

For quantitative and qualitative disclosures about market risk affecting us, see “Quantitative and Qualitative Disclosure about Market Risk” in Item 7A of Part II of our Annual Report on Form 10-K for the year ended December 31, 2012. As of June 30, 2013, our exposure to market risk has not changed materially since December 31, 2012.

 

Item 4. Controls and Procedures

Disclosure Controls and Procedures

The Company maintains a set of disclosure controls and procedures designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized, and reported within the time periods specified in Securities and Exchange Commission rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to the Company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. An evaluation was carried out under the supervision and with the participation of the Company’s management, including the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of the Company’s disclosure controls and procedures. Based on that evaluation, the CEO and CFO have concluded that as of June 30, 2013, the Company’s disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed was accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There has been no change in the Company’s internal control over financial reporting that occurred during the first half of 2013 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

32


Table of Contents

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

In a complaint initially filed on July 6, 2011, and amended on August 25, 2011, in Multnomah County Circuit Court in Oregon, 17 former students of one of our previously closed therapeutic boarding school facilities allege claims for intentional and negligent infliction of emotional distress, battery, breach of contract and negligence arising out of their treatment in certain programs of our school. We and our subsidiaries, Aspen Education Group, Inc. (“Aspen”) and Mount Bachelor Educational Center, Inc. (“MBA”), are among the defendants in the pending litigation. The plaintiffs seek a total of $26.0 million in relief. A second and third suit were filed in November 2011 and January 2013, respectively, in Multnomah County Circuit Court in Oregon by 14 former and 13 former students, respectively, also alleging abuse. The plaintiffs seek a total of $23 million in relief in the second suit and a total of $19.5 million in relief in the third suit. We and the other defendants intend to defend vigorously the pending lawsuits. In consultation with counsel and based on our preliminary investigation into the facts alleged, we believe these cases are without merit. However, at this time, we are unable to predict the outcome of the lawsuit, the possible loss or range of loss, if any, after consideration of the extent of insurance coverage associated with the resolution of the lawsuit or any potential effect it may have on us or our operations. On May 10, 2012, Nautilus Insurance Corporation filed a complaint against CRC Health Group Inc. and certain related entities seeking declaratory relief in the federal district court in Portland, Oregon. The Complaint seeks a judicial determination as to whether the Nautilus general and healthcare professional liability insurance policies provide coverage for these suits against MBA and asks the court to enter judgment that the policies are null and void, or alternatively that the policies do not cover these specific lawsuits, and to declare that Nautilus has no duty to defend or indemnify MBA, Aspen or CRC. This litigation with Nautilus Insurance Corporation has been stayed pending resolution of the underlying suits against MBA. In consultation with counsel and based on our preliminary review of the matters alleged, we believe this suit is without merit and we are vigorously defending the matter.

In a complaint filed in August 2011, a suit against our New Life Lodge facility was brought by Kathy Mauk as administrator of the estate of Lindsey Poteet a/k/a Lindsey Richardson, deceased and on behalf of the wrongful death beneficiary of Lindsey Poteet a/k/a Lindsey Richardson, Arwen Richardson, vs. CRC Health Tennessee, Inc. dba New Life Lodge and CRC Health Group, Inc. dba New Life Lodge. The suit alleges negligence and medical malpractice resulting in wrongful death and seeks a total $32.0 million in compensatory and punitive damages. A second suit was brought in December 2012 against our New Life Lodge facility by Charity Comage as administrator of the estate of and on behalf of Savon Kinney, deceased vs CRC Health Tennessee, Inc. dba New Life Lodge and CRC Health Group, Inc. dba New Life Lodge, American Behavioral Consultants, LLC and Holly Liter, APN. The second suit alleges negligence and medical malpractice resulting in the wrongful death and seeking a total $14.5 million in compensatory and punitive damages. American Behavioral Consultants, LLC served as an independent contractor for New Life Lodge and Ms. Holly Liter was an employee of American Behavioral Consultants, LLC. A third suit has been filed against our New Life Lodge by Penny Bryant, mother of Patrick Bryant, deceased, vs. CRC Health Tennessee, Inc. and Jonathan Butler, M.D. This suit was originally filed in 2011 and then dismissed without prejudice in October 2012 and was re-filed in June 2013. This suit alleges negligence resulting in the wrongful death of Patrick Bryant and seeks a total of $13.0 million in compensatory and punitive damages. We intend to defend vigorously these lawsuits. In consultation with counsel and based on our preliminary investigation into the facts alleged, we believe these cases are without merit. Although the Company believes the amounts reserved are adequate based on currently available information, the estimation process involves a considerable amount of judgment by management and the ultimate amounts could vary materially.

Our New Life Lodge facility is currently responding to a civil investigative demand (“CID”) from the Office of the Attorney General of the State of Tennessee inquiring about possible false claims for payment related to services provided to TennCare recipients for the period 2007 to 2011. The United States Department of Justice is participating in this investigation and also has requested information from New Life Lodge. We are cooperating fully with the investigation. Such CIDs are often associated with previously filed qui tam actions, or lawsuits filed under seal under the False Claims Act (“FCA”). Qui tam actions are brought by private plaintiffs suing on behalf of the federal government for alleged FCA violations. The Company firmly believes that any false claims action is without merit. If litigation results, we intend to vigorously defend our position; however, we cannot predict the outcome or timing of such litigation. Although the Company believes that the amounts reserved are adequate based on currently available information, the estimation process involves a considerable amount of judgment by management and the ultimate amounts could vary materially.

 

33


Table of Contents

We are involved in other litigation and regulatory investigations arising in the ordinary course of business. After consultation with legal counsel, management estimates that these matters will be resolved without material adverse effect on our future financial position or results from operations and cash flows, except as discussed above.

 

Item 1A. Risk Factors

As of June 30, 2013, there have been no material changes to the factors disclosed in Item 1A Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2012.

 

Item 6. Exhibits

The Exhibit Index beginning on page 36 of this report sets forth a list of exhibits.

 

34


Table of Contents

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: August 14, 2013

 

CRC HEALTH CORPORATION

(Registrant)

By  

/s/ LEANNE M. STEWART

 

LeAnne M. Stewart,

Chief Financial Officer

(Principal Financial Officer and duly authorized signatory)

 

35


Table of Contents

CRC HEALTH CORPORATION

EXHIBIT INDEX

 

  31.1    Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer ‡
  31.2    Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer ‡
  32.1    Section 1350 Certification of Principal Executive Officer †
  32.2    Section 1350 Certification of Principal Financial Officer †
101.INS    XBRL Instance Document ‡
101.SCH    XBRL Taxonomy Extension Schema ‡
101.CAL    XBRL Taxonomy Extension Calculation Linkbase ‡
101.DEF    XBRL Taxonomy Extension Definition Linkbase ‡
101.LAB    XBRL Taxonomy Extension Label Linkbase ‡
101.PRE    XBRL Taxonomy Extension Presentation Linkbase ‡

 

Filed herewith.
Furnished herewith.

 

36